Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Serbia Health minister wants stricter public usage rules for smoking…
  • Bahrain Final stage of HTP digital stamp system to be implemented…
  • Ireland Tobacco and nicotine products bill is adopted…
  • United States Menthol cigarette proposed rule review to continue into 2024…
  • Brazil Dates released for consultation of resolution banning heated tobacco…
  • Azerbaijan National Assembly approves tax amendment in third reading…
  • Brazil Public consultation to review e-cig ban to be opened…
  • Czech Republic Tax bill sent for publication…
  • Portugal Parliament approves heated tobacco flavour ban bill…
  • Finland Tax bill changed to include liquid smokeless nicotine products…
  • United Kingdom New heated tobacco tax rate in effect…
  • Portugal State Budget 2024 approved, increased heated tobacco tax to come…
View all
News analysis

Study calls for better phrased risk-reduction claims, from trusted sources

Written by || 30th November 2020 || News analysis | Modern oral | Snus | North America United States

A survey has concluded that reduced-risk claims for snus are understood by smokers, but better wording and genuine statements from independent sources – not tobacco companies – would improve their credibility ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Regulatory report: synthetic nicotine in the US – ‘tobacco product’ or not?
Health claim or no, nicotine pouches are viewed in Canada as ‘medical devices’
Regulatory report: Q&A – US federal regulation of oral nicotine products

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy. 

    © 2023 Tamarind Media Limited (T/A TobaccoIntelligence)

    TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence, does not accept any liability or responsibility for information or views published.